Innospec Financials

OCT Stock

EUR 72.50 1.00 1.36%

Financial data analysis helps to validate if markets are presently mispricing Innospec. We were able to interpolate thirty-five available reported financial drivers for Innospec, which can be compared to its competitors. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Innospec to be traded at €70.33 in 90 days.

Covid

Interest Hikes

Innospec Balance Sheet Chart

At this time, Innospec's Other Assets are most likely to increase significantly in the upcoming years. The Innospec's current Short and Long Term Debt is estimated to increase to about 29.2 M, while Other Current Liabilities is projected to decrease to roughly 1 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Key indicators impacting Innospec's financial strength include:

Current Value

Last Year

Change From Last Year

10 Year Trend

Operating Income

149.2 M

208.3 M

Way Down

Slightly volatile

Innospec Stock Summary

Innospec competes with Abbott Laboratories, DANAHER (DAPSG), Merck, Advanced Micro, and Philip Morris. Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. INNOSPEC INC operates under Specialty Chemicals classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2000 people.

Foreign Associate	UK
Specialization	Basic Materials, Specialty Chemicals
Instrument	Germany Stock View All
Exchange	Frankfurt Exchange
ISIN	US45768S1050
Business Address	8310 South Valley
Sector	Chemicals
Industry	Materials
Benchmark	Dow Jones Industrial
Website	innospec.com
Phone	303 792 5554
Currency	EUR - Euro

You should never invest in Innospec without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Innospec Stock, because this is throwing your money away. Analyzing the key information contained in Innospec's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Innospec Key Financial Ratios

There are many critical financial ratios that Innospec's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Innospec reports annually and quarterly.

	Revenue	1.85 B
	Gross Profit	501.2 M
	EBITDA	42.7 M
	Net Income	35.6 M
	Total Asset	1.73 B

More Fundamentals

Innospec Key Balance Sheet Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	1.6B	1.6B	1.7B	1.7B	2.0B	1.6B
Other Current Liab	12.1M	8.9M	23.7M	1.2M	1.1M	1.0M
Other Liab	165.4M	171.1M	178.2M	126.1M	145.0M	151.5M
Net Tangible Assets	442M	497.9M	610.6M	634.2M	729.3M	383.7M
Retained Earnings	822.9M	924.2M	1.0B	1.0B	1.2B	803.8M
Accounts Payable	148.7M	165.3M	163.6M	163.8M	188.4M	130.6M
Cash	141.8M	147.1M	203.7M	289.2M	332.6M	349.2M
Other Assets	130.9M	133.8M	171.2M	61.1M	70.3M	110.7M
Net Receivables	284.5M	334.6M	359.8M	341.7M	393.0M	281.4M
Good Will	364.3M	358.8M	399.3M	382.5M	439.9M	388.4M
Inventory	277.6M	373.1M	300.1M	301M	346.2M	269.3M
Other Current Assets	4.6M	6.2M	3.7M	600K	540K	513K
Total Liab	537.9M	563.3M	557.8M	518.6M	596.4M	587.9M
Total Current Assets	728.1M	872.6M	885.7M	956.6M	1.1B	717.9M
Intangible Assets	57.5M	45M	57.3M	65.4M	58.9M	87.8M
Net Invested Capital	1.0B	1.0B	1.1B	1.2B	1.4B	1.2B
Net Working Capital	391.5M	466.8M	514.2M	585.2M	673.0M	449.0M

Innospec Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.

	2021	2022	2023	2024	2025	2026 (projected)
Interest Expense	4.8M	1.8M	1.5M	1.1M	1.3M	2.0M
Total Revenue	1.5B	2.0B	1.9B	1.8B	2.1B	1.6B
Gross Profit	434.9M	586.7M	591.1M	542.9M	624.3M	479.5M
Operating Income	130.3M	187.3M	161.6M	181.1M	208.3M	149.2M
Ebit	157.1M	74.8M	135.7M	192.1M	220.9M	149.0M
Research Development	37.4M	38.7M	41.7M	47.8M	55.0M	37.0M
Cost Of Revenue	1.0B	1.4B	1.4B	1.3B	1.5B	1.1B
Income Before Tax	134.4M	184.6M	174.4M	41.2M	37.1M	35.2M
Net Income	93.1M	133M	139.1M	35.6M	32.0M	30.4M
Income Tax Expense	38.2M	11M	41.3M	51.6M	59.3M	41.1M
Tax Provision	41.3M	51.6M	35.3M	5.6M	5.0M	4.8M
Net Interest Income	(1.5M)	(1.1M)	2.3M	9.3M	10.7M	11.2M
Ebitda	202.8M	87.5M	178.6M	225.8M	259.7M	196.1M

Innospec Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Innospec. It measures of how well Innospec is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Innospec brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Innospec had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Innospec has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (capital allocation) and investing in non-business activities like paying off debt or making acquisitions.

	2021	2022	2023	2024	2025	2026 (projected)
Change To Inventory	(62M)	(98.5M)	56.1M	(11.8M)	(10.6M)	(11.2M)
Investments	(36.2M)	(42.1M)	(71.1M)	(62M)	(55.8M)	(58.6M)
Change In Cash	36.5M	5.3M	106.7M	85.5M	98.3M	103.2M
Net Borrowings	(150.2M)	(61.1M)	(600K)	(100K)	(2.3M)	0.0
Depreciation	42.4M	39.7M	38.3M	43.5M	50.0M	45.5M
Dividends Paid	28.8M	31.7M	33.3M	(38.8M)	(34.9M)	(33.2M)
Capital Expenditures	39.1M	39.6M	71.2M	62.3M	71.6M	37.2M
Net Income	93.1M	133M	139.1M	35.6M	32.0M	30.4M
Change To Netincome	(700K)	21.1M	5.5M	(1.3M)	(1.5M)	(1.6M)
End Period Cash Flow	141.8M	147.1M	207.1M	289.2M	332.6M	349.2M
Free Cash Flow	54.1M	39.4M	142.1M	122.2M	140.5M	100.4M

Innospec Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Innospec's current stock value. Our valuation model uses many indicators to compare Innospec value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innospec competition to find correlations between indicators driving Innospec's intrinsic value. More Info.

Innospec is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innospec's earnings, one of the primary drivers of an investment's value.

Innospec Total Assets Over Time

Most indicators from Innospec's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innospec current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Innospec Stock please use our How to Invest in Innospec guide.The Innospec's current Issuance Of Capital Stock is estimated to increase to about 3.1 M, while Selling General Administrative is projected to decrease to roughly 293.4 M.

	2023	2024	2025	2026 (projected)
Gross Profit	591.1M	542.9M	624.3M	479.5M
Total Revenue	1.9B	1.8B	2.1B	1.6B

Gross Profit Total Revenue

Innospec fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Good Will	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Non Current Assets Total	Non Currrent Assets Other
Total Assets		-0.9	0.93	0.99	0.51	0.95	0.98	0.92	0.8	0.41	-0.59	0.97	0.93	0.9	-0.9	-0.29	0.66	0.83	0.01	0.96	0.01	-0.9	-0.38	0.96	0.15	0.75
Other Current Liab	-0.9		-0.72	-0.87	-0.55	-0.83	-0.86	-0.74	-0.71	-0.56	0.41	-0.83	-0.97	-0.72	0.96	0.16	-0.67	-0.8	0.13	-0.78	0.13	0.83	0.38	-0.93	-0.25	-0.77
Total Current Liabilities	0.93	-0.72		0.92	0.45	0.92	0.92	0.98	0.73	0.22	-0.71	0.97	0.75	0.98	-0.75	-0.4	0.58	0.66	-0.03	0.97	-0.03	-0.87	-0.33	0.86	0.03	0.66
Total Stockholder Equity	0.99	-0.87	0.92		0.47	0.98	0.99	0.9	0.81	0.38	-0.66	0.95	0.9	0.89	-0.84	-0.31	0.53	0.82	0.07	0.97	0.07	-0.93	-0.35	0.96	0.15	0.72
Other Liab	0.51	-0.55	0.45	0.47		0.51	0.4	0.53	0.19	0.82	-0.48	0.51	0.47	0.41	-0.5	0.43	0.48	0.42	-0.27	0.36	-0.27	-0.46	-0.2	0.57	0.47	0.75
Net Tangible Assets	0.95	-0.83	0.92	0.98	0.51		0.97	0.89	0.71	0.43	-0.72	0.93	0.84	0.91	-0.78	-0.21	0.45	0.84	0.1	0.94	0.1	-0.97	-0.23	0.96	0.25	0.77
Retained Earnings	0.98	-0.86	0.92	0.99	0.4	0.97		0.89	0.81	0.31	-0.66	0.95	0.9	0.9	-0.84	-0.38	0.51	0.82	0.09	0.97	0.09	-0.94	-0.34	0.95	0.11	0.7
Accounts Payable	0.92	-0.74	0.98	0.9	0.53	0.89	0.89		0.68	0.27	-0.66	0.97	0.75	0.95	-0.78	-0.31	0.64	0.6	-0.19	0.94	-0.19	-0.83	-0.3	0.86	0.11	0.66
Cash	0.8	-0.71	0.73	0.81	0.19	0.71	0.81	0.68		0.14	-0.54	0.73	0.74	0.69	-0.72	-0.64	0.44	0.6	0.24	0.82	0.24	-0.71	-0.73	0.68	-0.33	0.44
Other Assets	0.41	-0.56	0.22	0.38	0.82	0.43	0.31	0.27	0.14		-0.23	0.32	0.47	0.2	-0.41	0.59	0.4	0.59	0.05	0.2	0.05	-0.41	-0.13	0.52	0.58	0.67
Long Term Debt	-0.59	0.41	-0.71	-0.66	-0.48	-0.72	-0.66	-0.66	-0.54	-0.23		-0.64	-0.38	-0.67	0.36	0.3	0.01	-0.35	-0.1	-0.64	-0.1	0.73	0.35	-0.58	0.02	-0.51
Net Receivables	0.97	-0.83	0.97	0.95	0.51	0.93	0.95	0.97	0.73	0.32	-0.64		0.84	0.94	-0.86	-0.32	0.67	0.74	-0.07	0.97	-0.07	-0.87	-0.32	0.92	0.16	0.73
Good Will	0.93	-0.97	0.75	0.9	0.47	0.84	0.9	0.75	0.74	0.47	-0.38	0.84		0.74	-0.94	-0.24	0.69	0.83	-0.07	0.83	-0.07	-0.82	-0.41	0.93	0.17	0.73
Inventory	0.9	-0.72	0.98	0.89	0.41	0.91	0.9	0.95	0.69	0.2	-0.67	0.94	0.74		-0.75	-0.42	0.57	0.65	-0.08	0.94	-0.08	-0.89	-0.31	0.86	-0.01	0.68
Other Current Assets	-0.9	0.96	-0.75	-0.84	-0.5	-0.78	-0.84	-0.78	-0.72	-0.41	0.36	-0.86	-0.94	-0.75		0.27	-0.77	-0.74	0.18	-0.8	0.18	0.76	0.41	-0.89	-0.15	-0.77
Other Stockholder Equity	-0.29	0.16	-0.4	-0.31	0.43	-0.21	-0.38	-0.31	-0.64	0.59	0.3	-0.32	-0.24	-0.42	0.27		-0.07	0.02	-0.06	-0.45	-0.06	0.29	0.57	-0.15	0.78	0.11
Total Liab	0.66	-0.67	0.58	0.53	0.48	0.45	0.51	0.64	0.44	0.4	0.01	0.67	0.69	0.57	-0.77	-0.07		0.53	-0.25	0.56	-0.25	-0.38	-0.36	0.58	0.12	0.59
Deferred Long Term Liab	0.83	-0.8	0.66	0.82	0.42	0.84	0.82	0.6	0.6	0.59	-0.35	0.74	0.83	0.65	-0.74	0.02	0.53		0.38	0.73	0.38	-0.77	-0.14	0.87	0.4	0.77
Short Long Term Debt	0.01	0.13	-0.03	0.07	-0.27	0.1	0.09	-0.19	0.24	0.05	-0.1	-0.07	-0.07	-0.08	0.18	-0.06	-0.25	0.38		0.05	1.0	-0.06	-0.05	-0.03	-0.04	0.01
Total Current Assets	0.96	-0.78	0.97	0.97	0.36	0.94	0.97	0.94	0.82	0.2	-0.64	0.97	0.83	0.94	-0.8	-0.45	0.56	0.73	0.05		0.05	-0.88	-0.35	0.89	0.02	0.63
Short Term Debt	0.01	0.13	-0.03	0.07	-0.27	0.1	0.09	-0.19	0.24	0.05	-0.1	-0.07	-0.07	-0.08	0.18	-0.06	-0.25	0.38	1.0	0.05		-0.06	-0.05	-0.03	-0.04	0.01
Intangible Assets	-0.9	0.83	-0.87	-0.93	-0.46	-0.97	-0.94	-0.83	-0.71	-0.41	0.73	-0.87	-0.82	-0.89	0.76	0.29	-0.38	-0.77	-0.06	-0.88	-0.06		0.29	-0.94	-0.15	-0.76
Common Stock	-0.38	0.38	-0.33	-0.35	-0.2	-0.23	-0.34	-0.3	-0.73	-0.13	0.35	-0.32	-0.41	-0.31	0.41	0.57	-0.36	-0.14	-0.05	-0.35	-0.05	0.29		-0.25	0.64	-0.22
Property Plant Equipment	0.96	-0.93	0.86	0.96	0.57	0.96	0.95	0.86	0.68	0.52	-0.58	0.92	0.93	0.86	-0.89	-0.15	0.58	0.87	-0.03	0.89	-0.03	-0.94	-0.25		0.3	0.83
Non Current Assets Total	0.15	-0.25	0.03	0.15	0.47	0.25	0.11	0.11	-0.33	0.58	0.02	0.16	0.17	-0.01	-0.15	0.78	0.12	0.4	-0.04	0.02	-0.04	-0.15	0.64	0.3		0.4
Non Currrent Assets Other	0.75	-0.77	0.66	0.72	0.75	0.77	0.7	0.66	0.44	0.67	-0.51	0.73	0.73	0.68	-0.77	0.11	0.59	0.77	0.01	0.63	0.01	-0.76	-0.22	0.83	0.4

Click cells to compare fundamentals

Innospec Account Relationship Matchups

Innospec fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	1.6B	1.6B	1.7B	1.7B	2.0B	1.6B
Other Current Liab	12.1M	8.9M	23.7M	1.2M	1.1M	1.0M
Other Liab	165.4M	171.1M	178.2M	126.1M	145.0M	151.5M
Net Tangible Assets	442M	497.9M	610.6M	634.2M	729.3M	383.7M
Retained Earnings	822.9M	924.2M	1.0B	1.0B	1.2B	803.8M
Accounts Payable	148.7M	165.3M	163.6M	163.8M	188.4M	130.6M
Cash	141.8M	147.1M	203.7M	289.2M	332.6M	349.2M
Other Assets	130.9M	133.8M	171.2M	61.1M	70.3M	110.7M
Net Receivables	284.5M	334.6M	359.8M	341.7M	393.0M	281.4M
Good Will	364.3M	358.8M	399.3M	382.5M	439.9M	388.4M
Inventory	277.6M	373.1M	300.1M	301M	346.2M	269.3M
Other Current Assets	4.6M	6.2M	3.7M	600K	540K	513K
Total Liab	537.9M	563.3M	557.8M	518.6M	596.4M	587.9M
Total Current Assets	728.1M	872.6M	885.7M	956.6M	1.1B	717.9M
Intangible Assets	57.5M	45M	57.3M	65.4M	58.9M	87.8M
Net Invested Capital	1.0B	1.0B	1.1B	1.2B	1.4B	1.2B
Net Working Capital	391.5M	466.8M	514.2M	585.2M	673.0M	449.0M

Innospec February 15, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Innospec help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Innospec. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innospec based on widely used predictive technical indicators. In general, we focus on analyzing Innospec Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innospec's daily price indicators and compare them against related drivers.

	Downside Deviation	1.44
	Information Ratio	0.0747
	Maximum Drawdown	6.3
	Value At Risk	(2.19)
	Potential Upside	3.01

Complementary Tools for Innospec Stock analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.

	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Global Correlations Find global opportunities by holding instruments from different markets
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC